Sexual Function in High-risk Pregnant Women
Launched by KARABUK UNIVERSITY · Nov 8, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the sexual health of pregnant women who are facing high-risk pregnancies. High-risk pregnancies can involve various complications that require special medical attention. The study aims to understand how these pregnancies affect women's sexual function, which is an important aspect of their overall well-being during this time.
To participate in this study, women must be 18 years or older, pregnant, and in their third trimester (the last three months of pregnancy). Unfortunately, those who are younger than 18, older than 40, or in their first two trimesters cannot take part. Women who join the study will have a chance to share their experiences and help researchers learn more about how high-risk pregnancies impact sexual function. This information could be valuable in improving care for pregnant women in the future. If you're interested in participating or want more information, please reach out to the study team.
Gender
FEMALE
Eligibility criteria
- • Inclusion Criteria: - Pregnant women over 18 years old, -Pregnant women 39 years old and under, -Pregnant women in their 3rd trimester.
- • Exclusion Criteria: - Pregnant women under 18 years old, -Pregnant women over 40 years old, -Pregnant women in their 1st or 2nd trimester.
About Karabuk University
Karabuk University is a distinguished educational institution located in Turkey, dedicated to advancing scientific research and innovation across various fields, including healthcare. As a clinical trial sponsor, the university plays a pivotal role in facilitating cutting-edge research aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a commitment to ethical standards and rigorous scientific methodology, Karabuk University collaborates with healthcare professionals and researchers to design and implement clinical trials that address pressing health challenges, ultimately striving to enhance treatment options and promote public health initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Sisli, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported